Harvard Bioscience Inc. (HBIO)
NASDAQ: HBIO
· Real-Time Price · USD
0.45
-0.22 (-32.86%)
At close: May 30, 2025, 3:59 PM
0.45
-0.44%
After-hours: May 30, 2025, 05:57 PM EDT
-32.86% (1D)
| Bid | 0.43 |
| Market Cap | 19.9M |
| Revenue (ttm) | 91.4M |
| Net Income (ttm) | -58.05M |
| EPS (ttm) | -1.31 |
| PE Ratio (ttm) | -0.34 |
| Forward PE | 11.26 |
| Analyst | Hold |
| Ask | 0.45 |
| Volume | 12,895,097 |
| Avg. Volume (20D) | 10,836,938 |
| Open | 0.58 |
| Previous Close | 0.67 |
| Day's Range | 0.43 - 0.58 |
| 52-Week Range | 0.28 - 3.60 |
| Beta | 1.45 |
About HBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HBIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+11.78%
Harvard Bioscience shares are trading higher after...
Unlock content with
Pro Subscription
2 months ago
-10.1%
Harvard Bioscience shares are trading lower. The company reported Q4 financial results.
2 months ago · seekingalpha.com
Harvard Bioscience, Inc. (HBIO) Q4 2024 Earnings Call TranscriptHarvard Bioscience, Inc. (NASDAQ:HBIO ) Q4 2024 Results Conference Call March 12, 2025 8:00 AM ET Company Participants Kathryn Flynn - Corporate Controller Jim Green - Chairman, President & CEO Jennif...